← Back
$CRBP All transactions

Corbus Pharmaceuticals Holdings, Inc.

A

$ Value

$0

Shares

85,095

Price

$0

Filed

Jan 16

Insider

Name

Hodgson Ian

Title

Chief Operating Officer

CIK

0002057525

Roles

Officer

Transaction Details

Transaction Date

2026-01-14

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

85,095

Footnotes

On January 14, 2026, the Reporting Person was granted 28,365 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service. | This amount includes 53,108 unvested RSUs subject to each grant's vesting schedule as previously reported. | The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027.

Filing Info

Accession No.

0001193125-26-015430

Form Type

4

Issuer CIK

0001595097

Hodgson Ian's History

Date Ticker Type Value
2026-02-17 CRBP $6K
2026-02-03 CRBP $20K
2026-01-14 CRBP A $0
2026-01-14 CRBP A $0

Other Insiders at CRBP (90d)

Insider Bought Sold Last
Moran Sean F.
Chief Financial Officer
$37K 2026-02-13
Cohen Yuval
Chief Executive Officer
$108K 2026-02-13
Smethurst Dominic
Chief Medical Officer
$77K 2026-03-02
Hodgson Ian
Chief Operating Officer
$26K 2026-02-17